Marschall S. Runge's most recent trade in Lilly(Eli) & Co was a trade of 335 Common Stock done at an average price of $597.6 . Disclosure was reported to the exchange on Nov. 20, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Lilly(Eli) & Co | Marschall S. Runge | Director | Grant, award, or other acquisition of securities at price $ 597.60 per share. | 20 Nov 2023 | 335 | 16,593 (0%) | 0% | 597.6 | 200,196 | Common Stock |
Lilly(Eli) & Co | Marschall S. Runge | Director | Grant, award, or other acquisition of securities at price $ 361.17 per share. | 21 Nov 2022 | 498 | 16,087 (0%) | 0% | 361.2 | 179,863 | Common Stock |
Lilly(Eli) & Co | Marschall S. Runge | Director | Purchase of securities on an exchange or from another person at price $ 246.78 per share. | 01 Mar 2022 | 202 | 15,436 (0%) | 0% | 246.8 | 49,850 | Common Stock |
Lilly(Eli) & Co | Marschall S. Runge | Director | Grant, award, or other acquisition of securities at price $ 258.43 per share. | 15 Nov 2021 | 677 | 15,181 (0%) | 0% | 258.4 | 174,957 | Common Stock |
Lilly(Eli) & Co | Marschall S. Runge | Director | Grant, award, or other acquisition of securities at price $ 140.59 per share. | 16 Nov 2020 | 1,245 | 14,279 (0%) | 0% | 140.6 | 175,035 | Common Stock |